Healius (ASX:HLS) Current Deferred Revenue: A$0 Mil (As of Dec. 2025)


ASX:HLS Healius Ltd ASX:HLS
54 GF Score
Price A$0.39
GF Value A$1.02
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Healius Current Deferred Revenue?

Healius ASX:HLS -1.28% 54 Current Deferred Revenue is A$0 Mil as of Dec. 2025. GuruFocus rates ASX:HLS with a GF Score™ of 54/100 and a GF Value™ of A$1.02 (Possible Value Trap). The stock has 7 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Healius's current deferred revenue for the quarter that ended in Dec. 2025 was A$0 Mil.

Healius Current Deferred Revenue Related Terms

Healius Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Healius's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healius Current Deferred Revenue Chart

Healius Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Healius Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:HLS
54GF Score
Healius Ltd ASX:HLS
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of A$0 Mil mean?
Healius (ASX:HLS) has a Current Deferred Revenue of A$0 Mil as of Dec. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Healius and its competitors.
Is Healius' Current Deferred Revenue too high?
Healius' current Current Deferred Revenue is A$0 Mil. Overall, Healius has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healius' Current Deferred Revenue compare to TMO and DHR?
Healius' Current Deferred Revenue of A$0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Diagnostics & Research company?
A good Current Deferred Revenue depends on the Medical Diagnostics & Research industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Healius and its competitors. Healius's current Current Deferred Revenue is A$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healius stock overvalued right now?
Based on GuruFocus' analysis, Healius (ASX:HLS) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.02, compared to a current price of A$0.39 — trading 62.3% below its estimated fair value. The current Current Deferred Revenue is A$0 Mil. Healius' overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Healius (ASX:HLS), the current Current Deferred Revenue is A$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healius (ASX:HLS) Overvalued in 2026?

Based on GuruFocus' analysis, Healius stock appears to be undervalued. The current stock price of A$0.39 is trading 62.3% below its estimated GF Value™ of A$1.02. GuruFocus considers Healius to be Possible Value Trap.

Key valuation signals for ASX:HLS:

  • Current Deferred Revenue: A$0 Mil
  • GF Value™: A$1.02 vs. price of A$0.39 (62.3% below fair value)
  • GF Score™: 54/100 with 7 warning signs

No single metric tells the full story. See the ASX:HLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healius Business Description

Other Exchanges PGZ:Germany
Address 161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
54GF Score

Get the complete analysis for ASX:HLS

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.39
Price
A$1.02
GF Value